Short and long term complications of device closure of atrial septal defect and patent foramen ovale: Meta‐analysis of 28,142 patients from 203 studies

Abacı, Adnan; Ünlü, Serkan; Alsancak, Yakup; Kaya, Ülker; Sezenöz, Burak

doi:10.1002/ccd.24875

Cited by 140 publications

(122 citation statements)

References 185 publications

Supporting

Mentioning

106

Contrasting

Unclassified

Order By: Relevance

“…Although atrioventricular block resolution often occurs with ste roids, certain characteristics of the ventricular septal defect and placement of the occluder 249 250 In a metaanalysis of 172 series comprising >13 000 patients, the incidence of atrioventricular block was 0.4%. 251 The overall risk of major periprocedural complications was 0% to 9.4% in the studies, with a pooled risk of 1.6%. In a recent series of 706 patients undergoing atrial septal defect closure with an Amplatzer device, the risk of atrioventricular block was 0.85%.…”

Section: Transcatheter Structural Interventionsmentioning

confidence: 87%

Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association

Sandau¹,

Funk²,

Auerbach³

et al. 2017

Circulation

206

214

View full text Add to dashboard Cite

Background and Purpose: This scientific statement provides an interprofessional, comprehensive review of evidence and recommendations for indications, duration, and implementation of continuous electro cardiographic monitoring of hospitalized patients. Since the original practice standards were published in 2004, new issues have emerged that need to be addressed: overuse of arrhythmia monitoring among a variety of patient populations, appropriate use of ischemia and QT-interval monitoring among select populations, alarm management, and documentation in electronic health records. Methods: Authors were commissioned by the American Heart Association and included experts from general cardiology, electrophysiology (adult and pediatric), and interventional cardiology, as well as a hospitalist and experts in alarm management. Strict adherence to the American Heart Association conflict of interest policy was maintained throughout the consensus process. Authors were assigned topics relevant to their areas of expertise, reviewed the literature with an emphasis on publications since the prior practice standards, and drafted recommendations on indications and duration for electrocardiographic monitoring in accordance with the American Heart Association Level of Evidence grading algorithm that was in place at the time of commissioning. Results: The comprehensive document is grouped into 5 sections: (1) Overview of Arrhythmia, Ischemia, and QTc Monitoring; (2) Recommendations for Indication and Duration of Electrocardiographic Monitoring presented by patient population; (3) Organizational Aspects: Alarm Management, Education of Staff, and Documentation; (4) Implementation of Practice Standards; and (5) Call for Research. Conclusions: Many of the recommendations are based on limited data, so authors conclude with specific questions for further research.

show abstract

Section: Transcatheter Structural Interventionsmentioning

confidence: 87%

Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association

Sandau¹,

Funk²,

Auerbach³

et al. 2017

Circulation

206

214

View full text Add to dashboard Cite

show abstract

“…17 Recently Abaci et al reported multicenter meta-analysis of 28, 142 patients who underwent ASD percutaneous device closure in 203 centers. 18 Peri-procedural major complications found in 1.6% cases and most common were device embolization requiring surgery. The reported significant complications of ASD device closure include cardiac perforation, device malposition, embolization, residual shunts, vascular trauma, thrombus formation with embolic events, AV valve or aortic valve regurgitation, atrial arrhythmias, infective endocarditis and sudden death.…”

Section: Resultsmentioning

confidence: 98%

Percutaneous transcatheter intervention in a cyanotic congenital heart disease at tertiary care hospital in Western Rajasthan: a single centre experience

et al. 2017

View full text Add to dashboard Cite

Background: Treatment of congenital heart disease (CHD) is either surgical or interventional. Medical management is mainly symptomatic or palliative. Although surgery is the main mode of treatment but in the recent past nonsurgical interventional method is replacing it because of its multiple advantages over surgical procedures. In this article, we report the success rate of the percutaneous transcatheter device closure procedures in our tertiary care hospital. Methods: The aim of this study is to review the short-term outcome of the non-surgical interventional treatment of congenital heart diseases. We included percutaneous transcatheter device closure of atrial septal defect (ASD), ventricular septal defect (VSD), patent ductus arteriosus (PDA) and ruptured sinus of valsalva aneurysm (SVA) performed at our hospital between September 2014 and November 2016. Results: We performed total 28 cases of ASD device, 3 cases of VSD device, 12 cases of PDA device, 2 cases of ruptured SVA device closures. Almost all our intervention procedures were successful except two cases of failure of ASD closure. There was no mortality and major complication related to procedures. All patients of successful interventional treatment are enjoying new life without any morbidity. Conclusions: Percutaneous transcatheter device closure for suitably selected cases of a cyanotic CHDs including ASD, VSD, PDA and ruptured SVA may be an alternative, lucrative, safe and effective option with least morbidity and mortality.

show abstract

“…Freedom from residual shunt was higher in percutaneous group than surgery (98.6% vs 91.3%). 22,23 In our series, out of 60 patients attempted for ASD device closure, 56 were successful, in 2 patients abandoned the procedure due to unsuitable rims, in one patient, a 24 mm Amplatzer device embolized to RV, another 16 mm device embolized to PA, which were subsequently surgically removed with patch closure of ASDs. We had no mortality.…”

Section: Resultsmentioning

confidence: 99%

Recent Advancement in Non-surgical Interventional Treatment in Congenital Heart Disease at National Institute of Cardiovascular Disease (NICVD)-a Tertiary Care Hospital of Bangladesh

et al. 2014

View full text Add to dashboard Cite

Background: Treatment of Congenital Heart Disease (CHD) is either Surgical or Interventional. Medical management is mainly symptomatic / palliative. Although surgery is the main mode of treatment but in the recent past non-surgical Interventional method is replacing it because of its multiple advantages over surgical procedures. Since 2005, we started our journey in National Institute of Cardiovascular Diseases with a PDA device closure. In this article we tried to review the success rate of the interventional procedures in this hospital. Methods: The aim of this retrospective study is to review the short term & Intermediate outcome of the non surgical interventional treatment of congenital heart diseases. We included all the interventional rocedures done in this Institute since 2005 upto December 2013. Results: During this period, we performed total 150 cases of patent ductus arteriosus (PDA) device, 20 cases of PDA Coil closure, 60 cases of atrial septal defect (ASD) device, 90 cases of Balloon Pulmonary Valvuloplasty (BPV), 20 cases of Balloon Aortic Valvuloplasty (BAV), 22 cases of Coarctation Balloon Angioplasty, 35 cases of Mitral Valvuloplasty (PTMC), 15 cases of Balloon Atrial Septostomy. Almost all of our intervention procedures were successful except one case of mortality related to procedure of PDA device closure, 4 device embolization (2 ASD & 2 PDA) and one case of PDA coil with persistent Intravascular hemolysis. All the embolized devices were subsequently retrieved surgically with repair. All other patients of interventional treatment are enjoying new life without any morbidity. Conclusion: Thus, we concluded that interventional methods of suitably selected case of congenital heart disease may be an alternative lucrative safe & effective option of remedy for many of the congenital heart diseases. DOI: http://dx.doi.org/10.3329/cardio.v6i2.18354 Cardiovasc. j. 2014; 6(2): 133-142

show abstract

Short and long term complications of device closure of atrial septal defect and patent foramen ovale: Meta‐analysis of 28,142 patients from 203 studies

Abstract: Device closure of ASD and PFO are associated with non-negligible serious complications, both in early and long-term.

Cited by 140 publications

References 185 publications

Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association

Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association

Percutaneous transcatheter intervention in a cyanotic congenital heart disease at tertiary care hospital in Western Rajasthan: a single centre experience

Recent Advancement in Non-surgical Interventional Treatment in Congenital Heart Disease at National Institute of Cardiovascular Disease (NICVD)-a Tertiary Care Hospital of Bangladesh

Contact Info

Product

Resources

About